NFA
FPRX

Nationwide Fund Advisors’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Nationwide Fund Advisors’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-70,059
Closed -$2.87M – 2592
2017
Q3 		$2.87M Buy
70,059
+4,208
+6% +$132K 0.01% 1289
2017
Q2 		$1.98M Buy
65,851
+6,451
+11% +$201K 0.01% 1432
2017
Q1 		$2.15M Buy
59,400
+1,771
+3% +$78.1K 0.01% 1360
2016
Q4 		$2.89M Buy
57,629
+3,547
+7% +$186K 0.01% 1245
2016
Q3 		$2.84M Buy
54,082
+3,472
+7% +$166K 0.01% 1239
2016
Q2 		$2.09M Buy
50,610
+6,560
+15% +$285K 0.01% 1336
2016
Q1 		$1.79M Sell
44,050
-676
-2% -$23.2K 0.01% 1401
2015
Q4 		$1.86M Sell
44,726
-2,533
-5% -$84.9K 0.01% 1395
2015
Q3 		$727K Sell
47,259
-760
-2% -$16.3K ﹤0.01% 1896
2015
Q2 		$1.19M Buy
48,019
+1,821
+4% +$40.6K ﹤0.01% 1758
2015
Q1 		$1.06M Buy
46,198
+11,812
+34% +$298K ﹤0.01% 1854
2014
Q4 		$928K Sell
34,386
-2,160
-6% -$37.2K ﹤0.01% 1849
2014
Q3 		$429K Buy
36,546
+2,650
+8% +$33.4K ﹤0.01% 2296
2014
Q2 		$527K Buy
33,896
+7,930
+31% +$114K ﹤0.01% 2232
2014
Q1 		$510K Buy
25,966
+21,763
+518% +$370K ﹤0.01% 2056
2013
Q4 		$71K Buy
+4,203
New +$52.2K ﹤0.01% 3029

Other funds holding FPRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Nationwide Fund Advisors's FPRX Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Five Prime Therapeutics, Inc. (FPRX) in Q4 2017, closing a stake of 70,059 shares — an estimated $2.87M sold.

Nationwide Fund Advisors first reported a position in FPRX in Q4 2013 and held it in 16 quarters. The position peaked at $2.89M in Q4 2016. 137 funds tracked by Wall St. Rank hold FPRX as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Five Prime Therapeutics, Inc. position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 70,059 Five Prime Therapeutics, Inc. shares in Q4 2017, an estimated $2.87M.
  • Nationwide Fund Advisors first reported a position in Five Prime Therapeutics, Inc. in Q4 2013 and held it in 16 quarters.
  • Nationwide Fund Advisors's Five Prime Therapeutics, Inc. position peaked at $2.89M in Q4 2016.
  • 137 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.